Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has submitted its quarterly financial results for the period ended September 30, 2025 to the NSE, as required under listing regulations. The actual detailed financial figures, segment performance, and year-on-year comparisons are contained in the submitted results document but are not included in this filing text. Investors would need to refer to the full results PDF for revenue, profit, margin, and other key metrics. The submission itself is a routine regulatory compliance step for listed companies following the close of each quarter.
No direct price-impacting information is disclosed in this filing beyond the confirmation that results have been filed. Shareholders and investors should review the detailed results document for actual performance numbers, which will determine market reaction.